Baseline demographic and clinical characteristics for the total first-time MI population (2009-2012, incl.) 
Patients with PCI (N=14852, 52%)
Patients without PCI (N=13597, 48%)
All patients n=14852
Clopidogrel n=9140 
Numbers in parentheses are percentages of total number of patients in the group; DAPT, dual antiplatelet therapy; PCI, percutaneous coronary intervention; IQR, interquartile range; Local hospital, hospital without catheterization laboratory; Main regional hospital, hospital with catheterization laboratory; Tertiary cardiac hospital, university hospital with catheterization laboratory; CABG, coronary artery bypass graft; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; NSAIDs, nonsteroidal anti-inflammatory drugs. No prescription 188 (5.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 188 (46.5%) 1,375 (41.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1,375 (83.6%)
Supplementary
Numbers in parentheses are percentages of total number of patients in the group; DAPT, dual antiplatelet therapy; PCI, percutaneous coronary intervention; IQR, interquartile range; Local hospital, hospital without catheterization laboratory; Main regional hospital, hospital with catheterization laboratory; Tertiary cardiac hospital, university hospital with catheterization laboratory; CABG, coronary artery bypass graft; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; NSAIDs, nonsteroidal anti-inflammatory drugs.
